Drug Trial Radar · NCT01591902
Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
Last checked: Nov 20, 2026Latest source record: Sep 11, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
129
Actual
Start
Jun 2012
Primary completion
May 2018
Study completion Aug 2018
Sponsor
- Lead sponsor
- TheratechnologiesIndustry
- Sponsor type
- Industry
- First posted
- May 4, 2012
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To show the non-inferiority of EGRIFTA® vs. placebo in the development or progression of Diabetic Retinopathy in HIV-infected subjects with concomitant abdominal lipohypertrophy and Type 2 diabetes mellitus (T2DM).
Conditions
- Diabetic Retinopathy
- HIV
Interventions
TesamorelinDrug
Daily 2 mg subcutaneous injections of tesamorelin
Placebo-ControlDrug
3.0 mL vials
Primary outcomes
What the sponsor says the trial is designed to measure.
- Difference in percentages of subjects with a 3-step or greater progression (from both eyes) on the Early Treatment Diabetic Retinopathy Study (ETDRS) PERSON scale.Time frame: 3 years
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
Southwest Center for HIV/AIDS
Phoenix, Arizona
Spectrum Medical Group
Phoenix, Arizona
5P21 Rand Schrader Clinic
Los Angeles, California
University of California CARE Clinic, Los Angeles
Los Angeles, California
Palmtree Clinical Research, Inc.
Palm Springs, California
UCSD Antiviral Research Center
San Diego, California
VAMC, Infectious Disease Section 111W
San Francisco, California
Capital Medical Associates, PC
Washington D.C., District of Columbia
Gary J. Richmond, M.D., PA
Fort Lauderdale, Florida
Orange County Health Department
Orlando, Florida
Triple O Research Institute
West Palm Beach, Florida
Rowan Tree Medical , P.A.
Wilton Manors, Florida
Be Well Medical Center, P.C.
Berkley, Michigan
Southampton Clinical Research, Inc d.b.a. Central West Clinical Research
St Louis, Missouri
Southampton Healthcare, Inc.
St Louis, Missouri
South Jersey Infectious Disease
Somers Point, New Jersey
Harold Hamm Diabetes Center at the University of Oklahoma
Oklahoma City, Oklahoma
Fanno Creek Clinic, LLC
Portland, Oregon
Central Texas Clinical Research
Austin, Texas
St. Hope Foundation, Inc.
Bellaire, Texas
Dallas VA Medical Center
Dallas, Texas
UT Southwestern Medical Center, Atten: HIV Research Unit
Dallas, Texas
Research Access Network
Houston, Texas
Virginia Mason Medical Center
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.